TITAN PHARMACEUTICALS INC Contracts & Agreements

Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024, by and among Titan Pharmaceuticals, Inc., TTNP Merger Sub, Inc., KE Sdn. Bhd., and BSKE Ltd (Filed With SEC on August 19, 2024)

Form of Settlement Agreement and General and Mutual Release between the Company and each of Eric Greenberg, Matthew C. McMurdo and David Natan (Filed With SEC on April 3, 2024)

Agreement, dated April 2, 2024, between the Company and Avraham Ben-Tzvi (Filed With SEC on April 3, 2024)

Resignation Agreement, dated April 2, 2024, between the Company and David Lazar (Filed With SEC on April 3, 2024)

Resignation Agreement, dated April 2, 2024, between the Company and Katherine Beebe DeVarney (Filed With SEC on April 3, 2024)

Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (Filed With SEC on November 14, 2023)

Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (Filed With SEC on September 19, 2023)

Form of Securities Purchase Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 19, 2023)

Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 19, 2023)

Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (Filed With SEC on September 18, 2023)

Form of Securities Purchase Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 18, 2023)

Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 18, 2023)

Amendment and Extension Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of August 25, 2023 (Filed With SEC on August 30, 2023)

Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (Filed With SEC on August 14, 2023)

Asset Purchase Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of July 26, 2023 (Filed With SEC on July 28, 2023)

Unsecured Promissory Note between Titan Pharmaceuticals, Inc. and David E. Lazar (Filed With SEC on July 28, 2023)

Form of Amendment to Employment Agreement with Kate DeVarney (Filed With SEC on May 15, 2023)

Employment Agreement, dated December 14, 2022, between Titan Pharmaceuticals, Inc. and David E. Lazar (Filed With SEC on December 15, 2022)

License Agreement between Titan Pharmaceuticals, Inc. and Ocular Therapeutix, Inc., dated as of December 6, 2022 (Filed With SEC on December 12, 2022)

Form of Stock Option Agreement (Filed With SEC on November 14, 2022)

Fifth Amended and Restated 2015 Omnibus Equity Incentive Plan (subject to stockholder approval) (Filed With SEC on November 14, 2022)

Form of Stock Option Agreement (Filed With SEC on September 21, 2022)

Form of Amendment to Employment Agreement with Marc Rubin (Filed With SEC on August 5, 2022)

Form of Amendment to Employment Agreement with Kate DeVarney (Filed With SEC on August 5, 2022)

Form of Registered Pre-Funded Warrant (Filed With SEC on February 3, 2022)

Form of Private Pre-Funded Warrant (Filed With SEC on February 3, 2022)

Form of Placement Warrant (Filed With SEC on February 3, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)

Placement Agency Agreement (Filed With SEC on February 3, 2022)

Amendment No. 2 to Employment Agreement dated April 2, 2019 between the registrant and Marc Rubin (Filed With SEC on October 28, 2021)

Form of Warrant (Filed With SEC on January 19, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 19, 2021)

Placement Agency Agreement (Filed With SEC on January 19, 2021)

Asset Purchase Agreement dated October 27, 2020 between Titan Pharmaceuticals, Inc. and JT Pharmaceuticals, Inc (Filed With SEC on November 16, 2020)

Underwriting Agreement dated October 28, 2028 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on November 2, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 27, 2020)

Form of Lock-Up and Voting Agreement (Filed With SEC on October 27, 2020)

Debt Settlement and Release Agreement (Filed With SEC on October 26, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 26, 2020)

Form of Lock-Up and Voting Agreement (Filed With SEC on October 26, 2020)

Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 19, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 19, 2020)

Form of Share Purchase Agreement (Filed With SEC on September 25, 2020)

Placement Agency Agreement (Filed With SEC on September 25, 2020)

Agreement for Co-Promotion Partnership, dated June 23, 2020, by and between Titan Pharmaceuticals, Inc. and Indegene, Inc (Filed With SEC on August 14, 2020)

Form of March 3, 2020 Warrant Amendment Agreement (Filed With SEC on March 30, 2020)

Description of the Registrants Common Stock (Filed With SEC on March 30, 2020)

Amendment No. 2 dated March 12, 2020 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on March 30, 2020)

Form of Warrant (Filed With SEC on January 7, 2020)

Form of Securities Purchase Agreement (Filed With SEC on January 7, 2020)

Placement Agency Agreement (Filed With SEC on January 7, 2020)

Underwriting Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 18, 2019)

Class B Warrant Agency Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (including Form of Class B Warrant) (Filed With SEC on October 18, 2019)

Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 8, 2019)

Form of 2019 Class B Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Class B Warrant (Filed With SEC on October 8, 2019)

Form of 2019 Class C Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company and Form of Class C Warrant (Filed With SEC on October 8, 2019)

Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on September 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on September 12, 2019)

Form of 2019 Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Offering Warrant (Filed With SEC on September 12, 2019)

Amendment dated September 10, 2019 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on September 12, 2019)

Amendment No. 2 dated September 10, 2019 to Asset Purchase, Supply and Support Agreement by and between Titan Pharmaceuticals, Inc. and L. Molteni & C. Dei Frattelli Alitti Societ... (Filed With SEC on September 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on August 8, 2019)

Form of Placement Warrant (Filed With SEC on August 8, 2019)

Form of Securities Purchase Agreement (Filed With SEC on August 8, 2019)

Placement Agency Agreement (Filed With SEC on August 8, 2019)

Sales Agreement dated April 25, 2019 between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on April 26, 2019)

Employment Agreement between the Registrant and Sunil Bhonsle (Filed With SEC on April 3, 2019)

Employment Agreement between the Registrant and Marc Rubin (Filed With SEC on April 3, 2019)

Employment Agreement between the Registrant and Katherine Beebe DeVarney (Filed With SEC on April 1, 2019)

Employment Agreement between the Registrant and Dane Hallberg (Filed With SEC on April 1, 2019)

Third Amended and Restated 2015 Omnibus Equity Incentive Plan (Filed With SEC on January 25, 2019)

Underwriting Agreement dated September 20, 2018 between Titan Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on September 25, 2018)

Warrant Agency Agreement dated September 25, 2018 between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on September 25, 2018)

Representatives Purchase Warrant (Filed With SEC on September 25, 2018)

Unsecured Convertible Loan Agreement dated September 18, 2018 (Filed With SEC on September 20, 2018)

Form of Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Offering Warrant (Filed With SEC on September 20, 2018)

Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on September 12, 2018)

Form of Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Offering Warrant (Filed With SEC on September 12, 2018)

Form of Representatives Purchase Warrant (Filed With SEC on September 12, 2018)

Form of Representatives Purchase Warrant (Filed With SEC on August 30, 2018)

Titan Pharmaceuticals, Inc. Second Amended and Restated 2015 Omnibus Equity Incentive Plan (Filed With SEC on August 14, 2018)

Distribution and Sublicense Agreement dated February 1, 2016 as amended by agreement dated August 2, 2018 between Titan Pharmaceuticals, Inc. and Knight Therapeutics Inc (Filed With SEC on August 14, 2018)

Amendment to lease for Registrants facilities dated March 21, 2016 (Filed With SEC on August 14, 2018)

Amendment to Employment Agreement with Sunil Bhonsle dated August 9, 2018 (Filed With SEC on August 14, 2018)

Amendment to Employment Agreement with Marc Rubin dated August 9, 2018 (Filed With SEC on August 14, 2018)

Amendment to Asset Purchase, Supply and Support Agreement dated August 3, 2018 (Filed With SEC on August 3, 2018)

Amendment to Titan Pharmaceuticals, Inc. Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on July 31, 2018)

Termination and Transition Services Agreement dated May 25, 2018 (Filed With SEC on May 30, 2018)

Amendment to Rights Agreement dated May 16, 2018 (Filed With SEC on May 16, 2018)

Form of Warrants (Filed With SEC on March 26, 2018)

Amended and Restated Venture Loan and Security Agreement dated March 21, 2018 (Filed With SEC on March 26, 2018)

Asset Purchase, Supply and Support Agreement dated March 21, 2018 (Filed With SEC on March 26, 2018)

Rights Agreement dated March 21, 2018 (Filed With SEC on March 26, 2018)

Amendment of Venture Loan and Security Agreement dated February 2, 2018 (Filed With SEC on February 7, 2018)

Binding Term Sheet dated November 28, 2017 between the Registrant and L. Molteni & C. dei F.lli Alitti Societ di Esercizio S.p.A (Filed With SEC on November 28, 2017)

TITAN PHARMACEUTICALS, INC. WARRANT TO PURCHASE SHARES OF STOCK (Loan A) (Filed With SEC on July 28, 2017)

VENTURE LOAN AND SECURITY AGREEMENT (Filed With SEC on July 28, 2017)

TITAN PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on September 30, 2016)

TITAN PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 1, 2016)

TITAN PHARMACEUTICALS, INC. AMENDED AND RESTATED 2015 OMNIBUS EQUITY INCENTIVE PLAN (Filed With SEC on August 3, 2016)

TITAN PHARMACEUTICALS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN (Filed With SEC on August 25, 2015)

TITAN PHARMACEUTICALS, INC. · Each Unit Consisting of One Share ofCommon Stock and 0.75 of a Class A Warrant, Each toPurchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 30, 2014)

TITANPHARMACEUTICALS, Inc. ClassA Warrant To Purchase Common Stock (Filed With SEC on September 30, 2014)

[FORMOF UNDERWRITER WARRANT] (Filed With SEC on September 30, 2014)

TITAN PHARMACEUTICALS, INC. 2014 INCENTIVE PLAN (Filed With SEC on March 31, 2014)

STOCK PURCHASE AGREEMENT (Filed With SEC on November 13, 2013)

CONFIDENTIALTREATMENT REQUESTED. INFORMATIONFOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN... (Filed With SEC on November 13, 2013)

Braeburn Pharmaceuticals Sprl c/o Apple Tree Partners 51 East 12th Street, 5th Flr. New York, NY 10003 (Filed With SEC on July 5, 2013)

RIGHTS AGREEMENT TITAN PHARMACEUTICALS, INC. and Continental Stock Transfer & Trust Company, as Rights Agent Dated May 28, 2013 TABLE OF CONTENTS (Filed With SEC on May 29, 2013)

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIALTREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH [*******] OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED... (Filed With SEC on May 29, 2013)

LICENSE AGREEMENT by and between TITAN PHARMACEUTICALS, INC. and BRAEBURN PHARMACEUTICALS SPRL dated December 14, 2012 TABLE OF CONTENTS (Filed With SEC on February 28, 2013)

AMENDMENT AGREEMENT (Filed With SEC on February 7, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on January 2, 2013)

LICENSE AGREEMENT by and between TITAN PHARMACEUTICALS, INC. and BRAEBURN PHARMACEUTICALS SPRL dated December 14, 2012 TABLE OF CONTENTS (Filed With SEC on December 19, 2012)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on April 10, 2012)

TITAN PHARMACEUTICALS, INC. SERIES A WARRANT dated as of April [ ], 2012 (the Date of Issuance) (Filed With SEC on April 10, 2012)

TITAN PHARMACEUTICALS, INC. SERIES B WARRANT dated as of April [ ], 2012 (the Date of Issuance) (Filed With SEC on April 10, 2012)

AMENDMENT NO. 2 TO RIGHTS AGREEMENT (Filed With SEC on April 10, 2012)

SUBSCRIPTION AGREEMENT (Filed With SEC on April 10, 2012)

AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on March 15, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2012)

RIGHTS AGREEMENT TITAN PHARMACEUTICALS, INC. and Continental Stock Transfer & Trust Company, as Rights Agent Dated December 20, 2011 TABLE OF CONTENTS (Filed With SEC on December 21, 2011)

ROYALTY PURCHASE AGREEMENT (Filed With SEC on November 17, 2011)

AMENDED AND RESTATED ROYALTY AGREEMENT (Filed With SEC on November 17, 2011)

AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENT (Filed With SEC on November 17, 2011)

W I T N E S S E T H: (Filed With SEC on November 17, 2011)

PAYING AGENT AGREEMENT (Filed With SEC on November 17, 2011)

Warrant to Purchase Common Stock of Titan Pharmaceuticals, Inc. (Filed With SEC on March 18, 2011)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 18, 2011)

FACILITY AGREEMENT (Filed With SEC on March 18, 2011)

SECURITY AGREEMENT (Filed With SEC on March 18, 2011)

ROYALTY AGREEMENT (Filed With SEC on March 18, 2011)

EQUITY OPTION AGREEMENT (Filed With SEC on March 18, 2011)

ROYALTY REPURCHASE AGREEMENT (Filed With SEC on March 18, 2011)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on December 29, 2010)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 15, 2010)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on November 15, 2010)

O Y S T E R P O I N T M A R I N A P L A Z A Tenth Amendment to Office Lease (Filed With SEC on August 16, 2010)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on June 16, 2010)

RESTRICTED STOCK AGREEMENT (Filed With SEC on November 10, 2008)

CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF (Filed With SEC on June 2, 2008)

400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080 Tel. (650) 244-4990 Fax(650) 244-4956 (Filed With SEC on April 30, 2008)

/s/ MARCRUBIN (Filed With SEC on March 12, 2008)

Marc Rubin Chief Executive Officer (Filed With SEC on March 12, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 27, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 19, 2007)

400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080 Tel. (650) 244-4990 Fax ###-###-#### (Filed With SEC on November 8, 2007)

ADDENDUM A INDEMNIFICATION PROVISIONS (Filed With SEC on April 26, 2007)

FORM OF COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on April 26, 2007)

COMMON STOCK PURCHASE AGREEMENT Dated March 14, 2007 (Filed With SEC on March 16, 2007)

/S/ THOMAS G.PINOU (Filed With SEC on March 16, 2006)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 30, 2005)

STANDBY EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on September 30, 2005)

TITAN PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on September 30, 2005)

OYSTER POINT MARINA PLAZA SeventhAmendment to Office Lease (Filed With SEC on March 15, 2005)

MERGER AGREEMENT (Filed With SEC on March 15, 2005)

ADDENDUM to DEVELOPMENTAND LICENSE AGREEMENT dated 25th January, 2000 between TITAN PHARMACEUTICALS, INC. and SCHERING AKTIENGESELLSCHAFT (Filed With SEC on March 15, 2005)

AMENDMENT TO EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2005)

TITANPHARMACEUTICALS, INC. 2002STOCK OPTION PLAN (Filed With SEC on March 31, 2003)

Category

Industry

Companies

Contracts

TITAN PHARMACEUTICALS INC Contracts & Agreements